Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

Importance: Tumor Treating Fields (TTFields) are an anti-mitotic treatment approved for treating newly diagnosed and recurrent glioblastoma, and mesothelioma. TTFields in glioblastoma comprise alternating electric fields (200 kHz) delivered continuously, ideally for ≥18 h/day, to the tumor bed via t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Lacouture, Mario E., Anadkat, Milan J., Ballo, Matthew T., Iwamoto, Fabio, Jeyapalan, Suriya A., La Rocca, Renato V., Schwartz, Margaret, Serventi, Jennifer N., Glas, Martin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399624/
https://ncbi.nlm.nih.gov/pubmed/32850308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01045
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak